Emergent BioSolutions | L'Utile Operativo





L'Utile Operativo Cambiamento Data
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Akebia Therapeutics USD 13.51M 27.82M 2025-03
ALKERMES USD 89.08M 3.9M 2025-09
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amarin USD -1.7M 8.47M 2025-09
ANI Pharmaceuticals USD 22.83M 7.66M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Coherus Biosciences USD -45.43M 3.13M 2025-03
Emergent BioSolutions USD -218M 69.9M 2023-06
Exact Sciences USD -25M 22.85M 2025-09
Exelixis USD 235.91M 20.45M 2025-12
Glaxosmithkline GBP 3.76B 1.32B 2025-09
Heron Therapeutics USD -5.66M 782K 2024-09
Ionis Pharmaceuticals USD -160.18M 300.02M 2025-09
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Lexicon Pharmaceuticals USD -55.35M 10.02M 2024-06
Lonza CHF 430M 104M 2024-12
Merck USD 6.24B 318M 2025-12
Moderna USD -857M 597M 2025-12
Myriad Genetics USD -23.3M 10.8M 2025-09
Nektar Therapeutics USD -34.34M 15.43M 2024-09
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Pacira USD 13.15M 2.92M 2025-09
Pfizer USD 4.65B 3.99B 2025-12
PTC Therapeutics USD 3.49M 38.35M 2025-09
Sanofi EUR 1.7B 2.17B 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
United Therapeutics USD 389.3M 112.4M 2025-09
Vanda Pharmaceuticals USD -40.66M 29.66M 2024-12
Xoma USD -15.64M 5.56M 2024-09


Emergent BioSolutions L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.